Faraz Ali
Chief Executive Officer at Tenaya Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Tenaya Therapeutics Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Tenaya Therapeutics Inc. | Open-market sale | โ3,390 | $0.79 | $2,678 |
| Feb 17, 2026 | Tenaya Therapeutics Inc. | Open-market sale | โ5,851 | $0.64 | $3,745 |
| Feb 17, 2026 | Tenaya Therapeutics Inc. | Open-market sale | โ3,979 | $0.64 | $2,547 |
| Feb 17, 2026 | Tenaya Therapeutics Inc. | Open-market sale | โ5,032 | $0.64 | $3,220 |
| Feb 3, 2026 | Tenaya Therapeutics Inc. | Grant or award | +158,600 | โ | โ |
| Nov 17, 2025 | Tenaya Therapeutics Inc. | Open-market sale | โ3,126 | $1.33 | $4,158 |
| Aug 18, 2025 | Tenaya Therapeutics Inc. | Open-market sale | โ5,720 | $1.25 | $7,150 |
| Aug 18, 2025 | Tenaya Therapeutics Inc. | Open-market sale | โ3,893 | $1.25 | $4,866 |
| Aug 18, 2025 | Tenaya Therapeutics Inc. | Open-market sale | โ4,920 | $1.25 | $6,150 |
| May 16, 2025 | Tenaya Therapeutics Inc. | Open-market sale | โ3,189 | $0.44 | $1,403 |
| Mar 10, 2025 | Tenaya Therapeutics Inc. | Open-market sale | โ5,794 | $0.54 | $3,129 |
| Mar 10, 2025 | Tenaya Therapeutics Inc. | Open-market sale | โ3,947 | $0.54 | $2,131 |
| Feb 6, 2025 | Tenaya Therapeutics Inc. | Grant or award | +107,500 | โ | โ |
| Feb 6, 2025 | Tenaya Therapeutics Inc. | Grant or award | +34,424 | โ | โ |
| Aug 16, 2024 | Tenaya Therapeutics Inc. | Open-market sale | โ5,802 | $2.89 | $16,768 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.